##### Table of Contents



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 10-KSB
 þ
    
    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 For the Fiscal Year Ended December 31, 2007
 o
    
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 For the Transition Period From  to
 Commission File Number 000-52320
 SENTISEARCH, INC.
  Delaware
(State or other jurisdiction of 
incorporation or organization)
    
    20-5655648
(I.R.S. Employer
Identification Number)
 1217 South Flagler Drive, 3rd Floor 
West Palm Beach, FL
    
    33401
    
    561-653-3284(Address of principal executive office)
    
    (Postal Code)
    
    (Issuers telephone number)
 None
 Common Stock, $.0001 par value per share
 o
 þ o
 o
    Large accelerated filer
    o

Accelerated filer
    o

Non-accelerated
    filer o
    (Do not check if a smaller reporting company)

Smaller reporting

Company þ o þ
    Documents
Incorporated By Reference:
  o þ




---



##### 



TABLE OF CONTENTS
 PAGEPART IFORWARD-LOOKING INFORMATION
    
    
    1ITEM 1 DESCRIPTION OF BUSINESS
    
    
    1ITEM 2 DESCRIPTION OF PROPERTY
    
    
    4ITEM 3 LEGAL PROCEEDINGS
    
    
    4ITEM 4 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
    
    
    4PART IIITEM 5 MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
    
    
    5ITEM 6 MANAGEMENTS DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
    
    
    5ITEM 7 FINANCIAL STATEMENTS
    
    
    F-1ITEM 8 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
    
    
    18ITEM 8A CONTROLS AND PROCEDURES
    
    
    18ITEM 8B OTHER INFORMATION
    
    
    18PART IIIITEM 9 DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS AND CORPORATE GOVERNANCE;
COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT
    
    
    19ITEM 10 EXECUTIVE COMPENSATION
    
    
    20ITEM 11 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
    
    
    21ITEM 12 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
    
    
    22ITEM 13 EXHIBITS
    
    
    23ITEM 14 PRINCIPAL ACCOUNTANT FEES AND SERVICES
    
    
    24EXHIBIT INDEXEX-31: CERTIFICATIONEX-32: CERTIFICATION
  -i-




---



##### Table of Contents



PART I
 
 Forward-looking Information
  
    
    discuss our future expectations;
    
    contain projections of our future results of operations or of our financial
condition; and
    
    state other forward-looking information.
  
 ITEM 1
    
    DESCRIPTION OF BUSINESS.
 Corporate History
 rd
 Overview
  Licensed Products and Services




---



##### Table of Contents




    
    food production;
    
    agricultural chemical companies; and
    
    pharmaceutical companies.
  2




---



##### Table of Contents




    
    obtaining research and development grants;
    
    developing commercially feasible products;
    
    filing and obtaining additional patents;
    
    entering into licensing, marketing or joint venture agreements;
    
    applying the olfaction intellectual property to a commercially viable product;
    
    developing and implementing a marketing plan in conjunction with a partner or
licensee;
    
    controlling quality and cost in the manufacturing process in conjunction with a
partner or licensee;
    
    selling products on a profitable basis in conjunction with a partner or licensee; and
    
    structuring an agreement that will enable us to enjoy the profits of our products.
  Competition
  Employees
  Government Regulation
  3




---



##### Table of Contents



ITEM 2
    
    DESCRIPTION OF PROPERTY.
 rd
 
 ITEM 3
    
    LEGAL PROCEEDINGS.
  
 ITEM 4
    
    SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
  4




---



##### Table of Contents



PART II
 
 ITEM 5
    
    MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.
 Market Information
  PricePeriod
    
    High
    
    Low2007First Quarter
    
    $
    2.50
    
    
    $
    0.22Second Quarter
    
    $
    0.22
    
    
    $
    0.17Third Quarter
    
    $
    0.24
    
    
    $
    0.18Fourth Quarter
    
    $
    0.22
    
    
    $
    0.182006Fourth Quarter
    
    $
    0.25
    
    
    $
    0.25
 Holders
  Dividends
  
 ITEM 6
    
    MANAGEMENTS DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.
 Forward-looking Information
  
    
    discuss our future expectations;
    
    contain projections of our future results of operations or of our financial
condition; and
    
    state other forward-looking information.
  5




---



##### Table of Contents



Introduction
   Critical Accounting Policies and Use of Estimates
  Impairment of intangibles
  Off-Balance-Sheet Arrangements
  Plan of Operations
 General
   6




---



##### Table of Contents



"-Liquidity and
Capital Resources .
   Product Research and Development
  Acquisition of Plant and Equipment and Other Assets
  Number of Employees
  Operating Expenses
  7




---



##### Table of Contents



Liquidity and Capital Resources
    Inflation
  Recent Accounting Pronouncements
  8




---



##### Table of Contents



9




---



##### Table of Contents



ITEM 7
    
    FINANCIAL STATEMENTS.
 SENTISEARCH, INC.
(A Development Stage Company)
INDEX TO FINANCIAL STATEMENTS
 Page No.Report of Independent Registered Accounting Firm
    
    F-2Financial Statements:Balance Sheet
    
    F-3Statements of Operations
    
    F-4Statements of Changes in Stockholders Equity (Deficiency)
    
    F-5Statements of Cash Flows
    
    F-6Notes to Financial Statements
    
    F-7
 F-1




---



##### Table of Contents



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
     RAICH ENDE MALTER CO. LLP
  F-2




---



##### Table of Contents



SENTISEARCH, INC.
(A Development Stage Company)
Balance Sheet
December 31, 2007
 ASSETSCurrent AssetsCash and cash equivalents
    
    $
    42,500Other AssetsLicense and
patent costs
    
    
    482,507Less: accumulated amortization
    
    
    (370,244
    )112,263Total Assets
    
    $
    154,763LIABILITIES AND STOCKHOLDERS (DEFICIENCY) EQUITYCurrent LiabilitiesAccounts payable and accrued expenses
    
    $
    122,042Notes payable  related party
    
    
    180,000302,042Stockholders (Deficiency) EquityCommon stock  $0.0001 par value, 8,000,000 shares
authorized, 7,694,542 shares outstanding
    
    
    769Additional paid in capital
    
    
    1,000,055Deficit accumulated during development stage
    
    
    (1,148,103
    )Total Stockholders (Deficiency) Equity
    
    
    (147,279
    )Total Liabilities and Stockholders (Deficiency) Equity
    
    $
    154,763
  F-3




---



##### Table of Contents



SENTISEARCH, INC.
(A Development Stage Company)
Statements of Operations
 For the periodApril 10, 2000(CommencementFor the Years
    
    
    of Business)Ended December 31,
    
    
    to December 31,2007
    
    
    2006
    
    
    2007Revenues
    
    $
    
    
    
    $
    
    
    
    $
    Direct costs
    
    
    
    
    
    
    
    
    
    
    Income after direct costs
    
    
    
    
    
    
    
    
    
    
    Operating expenses:General and administrative
    
    
    237,431
    
    
    
    255,065
    
    
    
    767,457Amortization of license and patent costs
    
    
    38,711
    
    
    
    182,504
    
    
    
    370,244276,142
    
    
    
    437,569
    
    
    
    1,137,701Other expense:Interest and financing expense
    
    
    10,402
    
    
    
    
    
    
    
    10,40210,402
    
    
    
    
    
    
    
    10,402Net loss before provision for income taxes
    
    
    (286,544
    )
    
    
    (437,569
    )
    
    
    (1,148,103
    )Income taxes
    
    
    
    
    
    
    
    
    
    
    Net loss
    
    $
    (286,544
    )
    
    $
    (437,569
    )
    
    $
    (1,148,103
    )Basic and diluted loss per share
    
    $
    (0.04
    )
    
    $
    (0.06
    )Weighted average shares outstanding 
basic and dilutive
    
    
    7,694,542
    
    
    
    7,694,542
  F-4




---



##### Table of Contents



SENTISEARCH, INC.
 (A Development Stage Company)
 Statements of Changes in Stockholders (Deficiency) Equity
 DeficitAccumulatedAdditional
    
    
    DuringCommon Stock
    
    
    Subscription
    
    
    Paid-in
    
    
    DevelopmentShares
    
    
    Amount
    
    
    Receivable
    
    
    Capital
    
    
    Stage
    
    
    TotalBalance  April 10, 2000 (Commencement of
Predecessor Business)
    
    
    
    
    
    $
    
    
    
    $
    
    
    
    $
    
    
    
    $
    
    
    
    $
    Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (47,763
    )
    
    
    (47,763
    )Balance  December 31, 2000
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (47,763
    )
    
    
    (47,763
    )Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (63,169
    )
    
    
    (63,169
    )Balance  December 31, 2001
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (110,932
    )
    
    
    (110,932
    )Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (65,936
    )
    
    
    (65,936
    )Balance  December 31, 2002
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (176,868
    )
    
    
    (176,868
    )Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (77,083
    )
    
    
    (77,083
    )Balance  December 31, 2003
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (253,951
    )
    
    
    (253,951
    )Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (109,169
    )
    
    
    (109,169
    )Balance  December 31, 2004
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (363,120
    )
    
    
    (363,120
    )Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (60,870
    )
    
    
    (60,870
    )Balance  December 31, 2005
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (423,990
    )
    
    
    (423,990
    )Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (320,747
    )
    
    
    (320,747
    )Balance  October 2, 2006
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (744,737
    )
    
    
    (744,737
    )Issuance of common
stock  October 3,
2006
    
    
    7,694,542
    
    
    
    769
    
    
    
    (769
    )
    
    
    
    
    
    
    
    
    
    
    Additional
contribution of
capital  October
10, 2006
    
    
    
    
    
    
    
    
    
    
    769
    
    
    
    249,231
    
    
    
    
    
    
    
    250,000Contribution to
capital of License
costs and
assumption of
liability  October
10, 2006
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    749,334
    
    
    
    
    
    
    
    749,334Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (116,822
    )
    
    
    (116,822
    )Balance  December 31, 2006
    
    
    7,694,542
    
    
    
    769
    
    
    
    
    
    
    
    998,565
    
    
    
    (861,559
    )
    
    
    137,775Stock-based
compensation
expense
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    1,490
    
    
    
    
    
    
    
    1,490Net loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (286,544
    )
    
    
    (286,544
    )Balance  December 31, 2007
    
    
    7,694,542
    
    
    $
    769
    
    
    $
    
    
    
    $
    1,000,055
    
    
    $
    (1,148,103
    )
    
    $
    (147,279
    )
  F-5




---



##### Table of Contents



SENTISEARCH, INC.
(A Development Stage Company)
Statements of Cash Flows
 For the periodApril 10, 2000(CommencementFor the
    
    
    of Business)Year Ended
    
    
    ThroughDecember 31,
    
    
    December 31,2007
    
    
    2006
    
    
    2007Cash flows from operating activitiesNet loss
    
    $
    (286,544
    )
    
    $
    (437,569
    )
    
    $
    (1,148,103
    )Stock-based compensation expense
    
    
    1,490
    
    
    
    
    
    
    
    1,490Adjustments to reconcile net loss to net cash provided by
operating activities:Amortization of license and patent costs
    
    
    38,711
    
    
    
    182,504
    
    
    
    370,244Increase in accounts payable and accrued expenses
    
    
    82,832
    
    
    
    72,958
    
    
    
    430,751Net cash used in operating activities
    
    
    (163,511
    )
    
    
    (182,107
    )
    
    
    (345,618
    )Cash flows
from investing activitiesAcquisition
of patents
    
    
    (41,882)
    
    
    
    
    
    
    
    (41,882
    )Net cash
used by investing activities
    
    
    (41,882
    )
    
    
    
    
    
    
    (41,882
    )Cash flows from financing activitiesProceeds from notes payable  related parties
    
    
    180,000
    
    
    
    
    
    
    
    180,000Proceeds from issuance of stock
    
    
    
    
    
    
    250,000
    
    
    
    250,000Net cash provided by financing activities
    
    
    180,000
    
    
    
    250,000
    
    
    
    430,000Net (decrease) increase in cash and cash equivalents
    
    
    (25,393
    )
    
    
    67,893
    
    
    
    42,500Cash and cash equivalents  beginning of period
    
    
    67,893
    
    
    
    
    
    
    
    Cash and cash equivalents  end of period
    
    $
    42,500
    
    
    $
    67,893
    
    
    $
    42,500Supplemental disclosures of cash flow informationNon-cash from financing activities:Assumption of liability by Sentigen Holding Corp.
    
    $
    
    
    
    $
    308,709
    
    
    $
    308,709Stock of Sentigen Holding Corp. issued for license costs
    
    $
    
    
    
    $
    
    
    
    $
    440,625
  F-6




---



##### Table of Contents



Notes to Financial Statements
 1. Organization and Nature of Operations
     2. Basis of Presentation
    3. Summary of Significant Accounting Policies
 F-7




---



##### Table of Contents



a.
    
    Cash and Cash Equivalents Cash and cash equivalents include liquid investments with
maturities of three months or less at the time of purchase.
 b.
    
    License and Patent Costs The costs of intangible assets that are purchased from others for use in
research and development activities and that have alternative future uses (in research and
development projects or otherwise) are accounted for in accordance with FASB Statement No.
142, Goodwill and Other Intangible Assets. The amortization of those intangible assets
used in research and development activities is a research and development cost. However,
the costs of intangibles that are purchased from others for a particular research and
development project and that have no alternative future uses (in other research and
development projects or otherwise) and therefore no separate economic values are research
and development costs at the time the costs are incurred. We determined that the licensing
and patent costs arising from our exclusive licensing agreement with The Trustees of Columbia
University have alternative future uses. These costs have been capitalized and are being
amortized on a straight-line basis through April 2010 (see Notes 6 and 7).
 c.
    
    Impairment Intangible and long-lived assets are reviewed for impairment whenever
events or changes in circumstances indicate that the carrying amount of the assets may not
be fully recoverable. A review for impairment includes comparing the carrying value of an
asset to an estimate of the undiscounted net future cash inflows over the life of the asset
or fair market value. An asset is considered to be impaired when the carrying value exceeds
the calculation of the undiscounted net future cash inflows or fair market value. An
impairment loss is defined as the amount of the excess of the carrying value over the fair
market value of the asset. We believe that none of our intangible and long-lived assets are
impaired as of December 31, 2007 (see Note 6).
 d.
    
    Estimates The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the dates of the financial statements and the reported amounts of
revenues and expenses during the reporting periods. Actual results could differ from those
estimates.
 e.
    
    Income Taxes Certain income and expense items are accounted for differently for
financial reporting and income tax purposes. Deferred tax assets and liabilities are
determined based on the difference between the financial statement and income tax basis of
assets and liabilities and the tax effect of net operating loss and tax credit
carry-forwards applying the enacted statutory tax rates in effect for the year in which the
differences are expected to reverse. Valuation allowances are established if it is
determined to be more likely than not that deferred tax assets will not be recovered.
 f.
    
    Loss Per Share The accompanying financial statements include loss per share calculated
as required by FASB Statement No. 128 Earnings Per Share on a pro-forma basis as if we
were a separate entity from the period April 10, 2000 (commencement of business) until
October 3, 2006 (our date of incorporation). Basic loss per share is calculated by dividing
net loss by the weighted average number of shares of common stock outstanding. Diluted loss
per share includes the effects of securities convertible into common stock, consisting of
stock options, to the extent such conversion would be dilutive. FASB Statement No. 128
prohibits adjusting the denominator of diluted Earnings Per Share for additional potential
common shares when a net loss from continuing operations is reported. As of December 31,
2007, SentiSearch, Inc. had no such securities outstanding or exercisable.
 g.
    
    Fair Value of Financial Instruments The carrying value of cash and cash equivalents
and accounts payable and accrued expenses approximates fair value because of the short-term
maturity of those instruments. The carrying amount of the Companys notes payable
approximate fair value because the effective yield of such instruments, which includes the
effects of contractual interest rates taken together with any discounts, is consistent with
current market rates of interest for instruments of comparable credit risk.
 h.
    
    Stock-Based Compensation Effective January 1, 2006, the Company adopted SFAS 123R,
Share-Based Payment (SFAS 123R). This statement is a revision of SFAS 123, and supersedes
APB Opinion No. 25, and its related implementation guidance. SFAS 123R addresses all forms
of share-based payment (SBP) awards including shares issued under employee stock purchase
plans, stock options, restricted stock and stock appreciation rights. Under SFAS 123R, SBP
awards result in a cost that is measured at fair value on the awards grant date, based on
the estimated number of awards that are expected to vest and will result in a charge to
operations. As the Company did not issue any employee share-based payments prior to January
1, 2006, there was no unrecognized compensation costs in any prior periods.
 F-8




---



##### Table of Contents



Stock-based compensation expense recognized in the Companys statements of operations for the
year ended December 31, 2007 includes compensation expense for the share-based payment awards
granted subsequent to December 31, 2005, based upon the grant date fair value estimated in
accordance with the provisions of SFAS 123R. The Company recognizes compensation expense for
stock option awards on a straight-line basis over the requisite service period of the award.
As stock-based compensation expense recognized in the year ended December 31, 2007 is based
upon awards ultimately expected to vest, it has been reduced for estimated forfeitures. SFAS
123R requires forfeitures to be estimated at the time of grant and revised, if necessary, in
subsequent periods if actual forfeitures differ from those estimates.
  4. Income Taxes
    December 31,2007
    
    
    2006Net operating loss carryforwards
    
    $
    116,163
    
    
    $
    2,887Amortization
    
    
    45,184
    
    
    
    43,842Less: Valuation allowance
    
    
    (161,347
    )
    
    
    (46,729
    )Net deferred tax assets
    
    $
    
    
    
    $
    
   F-9




---



##### Table of Contents



For the period April10, 2000 (Commencementof PredecessorFor the years ended December
    
    
    Business) to December31,
    
    
    31,2007
    
    
    2006
    
    
    2007At Statutory Rates
    
    $
    (97,425
    )
    
    $
    (148,774
    )
    
    $
    (390,355
    )State income taxes, net of
federal benefit
    
    
    (17,193
    )
    
    
    (26,254
    )
    
    
    (68,887
    )NOLs utilized by Sentigen
    
    
    
    
    
    
    297,895
    
    
    
    297,895Increase in valuation allowance
    
    
    114,618
    
    
    
    (122,867
    )
    
    
    161,347Provision for income taxes
    
    $
    
    
    
    $
    
    
    
    $
    
  5. Notes Payable
  6. Exclusive License Agreement
      F-10




---



##### Table of Contents



For the years ended:
    
    Expected amortization expense2008
    
    $
    32,7272009
    
    
    32,7272010
    
    
    10,910Total
    
    $
    76,364
 7.
    Patent
    Costs       For the years ended:
    
    Expected amortization expense2008
    
    $
    11,9662009
    
    
    11,9662010
    
    
    11,967Total
    
    $
    35,899
 8. Share-Based Payments
   Weighted Average
    
    
    Weighted Average
    
    
    Aggregate IntrinsicNumber of Options
    
    
    Exercise Price
    
    
    Contractual Term
    
    
    ValueBalance at January 1, 2006
    
    
    
    
    
    $
    Granted
    
    
    50,000
    
    
    
    0.18Balance at December 31, 2007
    
    
    50,000
    
    
    $
    0.18
    
    
    
    4.38
    
    
    $
    2,000Exercisable at December 31, 2007
    
    
    50,000
    
    
    $
    0.18
    
    
    
    4.38
    
    
    $
    2,000
   9. Recently Issued Accounting Pronouncements
  F-11




---



##### Table of Contents



10. Commitments and Contingencies
  F-12




---



##### Table of Contents



ITEM 8
    
    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE.
  
 ITEM 8A
    
    CONTROLS AND PROCEDURES.
 Controls and Procedures
  Changes in Internal Controls Over Financial Reporting
  Managements Report on Internal Control Over Financial Reporting
    
    
    Pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the Company;
    
    Provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting
principles, and that our receipts and expenditures are being made only in accordance with
authorizations of our management and directors; and
    
    Provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use or disposition of our assets that could have a material effect on the
financial statements.
 Internal Control over
Financial Reporting  Guidance for Smaller Public Companies
   
 ITEM 8B
    
    OTHER INFORMATION.
  18




---



##### Table of Contents



PART III
 
 ITEM 9
    
    DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS AND CORPORATE GOVERNANCE;
COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT.
 Directors and Executive Officer
  Name
    
    Age
    
    PositionJoseph K. Pagano
    
    
    63
    
    
    Chief Executive Officer, Secretary, Treasurer and Chairman of the Board of DirectorsFrederick R. Adler
    
    
    82
    
    
    DirectorThomas J. Livelli
    
    
    54
    
    
    DirectorErik R. Lundh
    
    
    38
    
    
    Director
      19




---



##### Table of Contents



Section 16(a) Beneficial Reporting Compliance
  Code of Ethics
  Committees
   
 ITEM 10
    
    EXECUTIVE COMPENSATION.
 Executive Officer Compensation.
  Director Compensation.
  Option awards (1)
    
    TotalName
    
    ($)
    
    ($)Joseph K. Pagano
    
    
    
    Frederick R. Adler
    
    
    
    Thomas J. Livelli
    
    
    
    Erik R. Lundh(2)
    
    $1,490
    
    $1,490
 
 (1)
    
    The amounts in this column represent the dollar amount recognized in accordance with SFAS
123R for financial statement reporting purposes with respect to the 2007 fiscal year for the fair
value of stock options granted in 2007. Assumptions used in the calculation of these amounts for
the 2007 fiscal year are included in Note 7 to our audited financial statements for the 2007 fiscal
year included elsewhere herein. 20




---



##### Table of Contents



(2)
    
    In connection with Mr. Lundhs appointment to the board of directors, on May 16, 2007, the
effective date of his appointment, Mr. Lundh received a one-time
special grant of an option to
purchase 50,000 shares of our common stock. The options vested immediately and were granted at an
exercise price equal to the closing price of our common stock on the grant date. The grant date
fair value per option for Mr. Lundhs stock option award was $0.18.  
 ITEM 11
    
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
MATTERS.
  21




---



##### Table of Contents



ITEM 12
    
    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
 Certain Relationships and Related Transactions
  Director Independence
  22




---



##### Table of Contents



ITEM 13
    
    EXHIBITS.
 Exhibit
    
    Description3.1
    
    Certificate of Incorporation of SentiSearch, Inc.*3.2
    
    Bylaws of SentiSearch, Inc.*4.1
    
    Specimen Common Stock Certificate of SentiSearch, Inc.**10.1
    
    Exclusive License Agreement dated April 10, 2000 between Sentigen Biosciences, Inc. (formerly known as
Sentigen Corp.), and The Trustees of Columbia University in the City of New York.*10.2
    
    Consent to the Assignment to SentiSearch, Inc. of the Exclusive License Agreement dated April 10, 2000
between Sentigen Biosciences, Inc. (formerly known as Sentigen Corp.), and The Trustees of Columbia
University in the City of New York: (1) Letter dated September 25, 2006 by Sentigen Biosciences, Inc.
requesting consent to assignment of the Exclusive License Agreement, and (2) Letter dated October 17, 2006
by Columbia University granting consent to the assignment of the Exclusive License Agreement.*10.3
    
    Separation and Distribution Agreement, dated as of October 10, 2006, between Sentigen Holding Corp. and
SentiSearch, Inc.*10.4
    
    Contribution Agreement, dated as of October 10, 2006, between Sentigen Holding Corp. and SentiSearch, Inc.*10.5
    
    Patent Assignment, dated October 10, 2006, by Sentigen Holding Corp. to SentiSearch, Inc.*10.6
    
    Form of Indemnification Agreement.*10.7
    
    Option Agreement dated May 16, 2007 by and between Erik R. Lundh and SentiSearch, Inc., incorporated by
reference to Exhibit 10.1 to SentiSearchs Form 8-K filed on May 18, 2007.10.8
    
    Form of Demand Promissory Note, incorporated by reference to Exhibit 10.1 to SentiSearchs Form 8-K filed
on June 22, 2007.31
    
    Certification of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the
Securities and Exchange Act of 1934, as amended.32
    
    Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
 
 *
    
    Incorporated by reference to SentiSearchs Registration Statement on Form 10-SB filed with the SEC on
November 15, 2006. File No. 000-52320.**
    
    Incorporated by reference to SentiSearchs Registration Statement on Amendment No. 1 to Form 10-SB filed
with the SEC on November 29, 2006. File No. 000-52320. 23




---



##### Table of Contents



ITEM 14
    
    PRINCIPAL ACCOUNTANT FEES AND SERVICES.
  December 31, 2006
    
    
    December 31, 2007(i) Audit Fees
    
    $
    58,000
    
    
    $
    35,000(ii) Audit Related Fees
    
    $
    0
    
    
    $
    0(iii) Tax Fees
    
    $
    0
    
    
    $
    0(iv) All Other Fees
    
    $
    0
    
    
    $
    0Total Fees
    
    $
    58,000
    
    
    $
    35,000
 Audit Fees
  Policy on Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditors
  24




---



##### Table of Contents



Signatures
  SENTISEARCH, INC.Date: March 28, 2008
    /s/ Joseph K. PaganoJoseph K. PaganoChief Executive Officer  Name
    
    Position
    
    Date/s/ Joseph K. Pagano

Joseph K. Pagano
    
    Chief Executive Officer,
Secretary and Treasurer,
Chairman of the Board,
Principal Executive Officer and
Principal Financial and
Accounting Officer
    
    March 28, 2008/s/ Frederick R. Adler

Frederick R. Adler
    
    Director
    
    March 28, 2008Thomas J. Livelli
    
    Director
    
    March 28, 2008/s/ Erik R. Lundh

Erik R. Lundh
    
    Director
    
    March 28, 2008




---



##### Table of Contents



EXHIBIT INDEX
 Exhibit
    
    Description3.1
    
    Certificate of Incorporation of SentiSearch, Inc.*3.2
    
    Bylaws of SentiSearch, Inc.*4.1
    
    Specimen Common Stock Certificate of SentiSearch, Inc.**10.1
    
    Exclusive License Agreement dated April 10, 2000 between Sentigen Biosciences, Inc. (formerly known as
Sentigen Corp.), and The Trustees of Columbia University in the City of New York.*10.2
    
    Consent to the Assignment to SentiSearch, Inc. of the Exclusive License Agreement dated April 10, 2000
between Sentigen Biosciences, Inc. (formerly known as Sentigen Corp.), and The Trustees of Columbia
University in the City of New York: (1) Letter dated September 25, 2006 by Sentigen Biosciences, Inc.
requesting consent to assignment of the Exclusive License Agreement, and (2) Letter dated October 17, 2006
by Columbia University granting consent to the assignment of the Exclusive License Agreement.*10.3
    
    Separation and Distribution Agreement, dated as of October 10, 2006, between Sentigen Holding Corp. and
SentiSearch, Inc.*10.4
    
    Contribution Agreement, dated as of October 10, 2006, between Sentigen Holding Corp. and SentiSearch, Inc.*10.5
    
    Patent Assignment, dated October 10, 2006, by Sentigen Holding Corp. to SentiSearch, Inc.*10.6
    
    Form of Indemnification Agreement.*10.7
    
    Option Agreement dated May 16, 2007 by and between Erik R. Lundh and SentiSearch, Inc., incorporated by
reference to Exhibit 10.1 to SentiSearchs Form 8-K filed on May 18, 2007.10.8
    
    Form of Demand Promissory Note, incorporated by reference to Exhibit 10.1 to SentiSearchs Form 8-K filed
on June 22, 2007.31
    
    Certification of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the
Securities and Exchange Act of 1934, as amended.32
    
    Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
 
 *
    
    Incorporated by reference to SentiSearchs Registration Statement on Form 10-SB filed with the SEC on
November 15, 2006. File No. 000-52320.**
    
    Incorporated by reference to SentiSearchs Registration Statement on Amendment No. 1 to Form 10-SB filed
with the SEC on November 29, 2006. File No. 000-52320.